Latest News and Press Releases

Reported positive clinical proof-of-concept data for OD-001 in a Phase 2a monotherapy trial for moderate to severe ulcerative colitis.

CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic malignancies, today announced that the first patient...

Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Next Generation Sequencing Services Market Size, Trends and Insights By Service...

Ecopipam, an investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug...

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies.For IND-enabling programs, conjugation process development timelines...

Austin, TX, USA, May 26, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Bioprocess Automation Software Market Size, Trends and Insights By Type...

Cash Runway Extended to Finance the Parkinson’s Program; Debt Paydown Improves Shareholder Equity Position  Jupiter, FL, May 21, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS)...

ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its...

Austin, TX, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cholera Vaccine Market Size, Trends and Insights By Type (Whole Cell v. Cholerae...